In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Atrium Medical Corp.

Division of Getinge AB

Latest From Atrium Medical Corp.

Stent Company To Pay $11.5m In Physician Kickback Settlement

Atrium Medical agreed to pay $11.5m to settle allegations that it violated the False Claims Act by promoting its iCast stent to physicians for arterial use even though the product was only approved for treating tracheobronchial obstructions.

Commercial Legal Issues

Getinge Postpones Financial Review Following FDA Feedback

The Swedish conglomerate pushed off a planned Capital Markets Day based on a communication from FDA about Getinge’s ongoing efforts to remediate its quality management systems. The firm did not disclose the details of the agency’s feedback, but explained that it added too much uncertainty for executives to discuss a financial outlook.

Medical Device Regulation

FDA Warning Letters

Hospira cited for QS violations in relation to Plum infusion pumps; maker of brachytherapy seeds failed to document complaints of leaking seeds. Seventeen warning letters listed by FDA from Oct. 9 through Nov. 12.

Hernia Repair: No Simple Solution

Hernia repair is a staple of the general surgeon’s practice, with more than two million procedures performed annually worldwide. However, the procedure has proven problematic due to the mesh products used to repair the hernia defect and their potential to cause complications over time. At the Fifth International Hernia Congress, held recently in New York City, physicians debated the pros and cons of the many hernia repair mesh products that are now available. Although the general consensus at the meeting was there is no “ideal mesh,” mesh manufacturers continue to innovate in this field, offering a host of new products for this $500+ million market, including a variety of biologic meshes for complex repairs, synthetic meshes with biologic-like properties, fully resorbable meshes, and meshes with bacteriostatic properties.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Cardiovascular
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Getinge AB
  • Senior Management
  • Steve Herweck, Chmn. & CEO
    Gary Sufat, VP, Fin.
  • Contact Info
  • Atrium Medical Corp.
    Phone: (603) 880-1433
    5 Wentworth Dr.
    Hudson, NH 03051